Global Immuno-oncology Therapy Market Research Report 2024
Report Overview:
Immuno-oncology therapy is a type of cancer treatment that harnesses the bodys immune system to target and destroy cancer cells. It includes therapies such as immune checkpoint inhibitors, cancer vaccines, and adoptive T cell therapies.
The Global Immuno-oncology Therapy Market Size was estimated at USD 1268.69 million in 2023 and is projected to reach USD 1652.16 million by 2029, exhibiting a CAGR of 4.50% during the forecast period.
This report provides a deep insight into the global Immuno-oncology Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immuno-oncology Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immuno-oncology Therapy market in any manner.
Global Immuno-oncology Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda
BioNTech SE
Allogene Therapeutics
IMAB-I-Mab Biopharma Co., Ltd.
Arcus Biosciences
Gritstone Oncology
Autolus Therapeutics
Rubius Therapeutics
Market Segmentation (by Type)
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Market Segmentation (by Application)
Hospitals
Ambulatory Surgical Center
Others
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Immuno-oncology Therapy Market
• Overview of the regional outlook of the Immuno-oncology Therapy Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immuno-oncology Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Markets Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Immuno-oncology therapy is a type of cancer treatment that harnesses the bodys immune system to target and destroy cancer cells. It includes therapies such as immune checkpoint inhibitors, cancer vaccines, and adoptive T cell therapies.
The Global Immuno-oncology Therapy Market Size was estimated at USD 1268.69 million in 2023 and is projected to reach USD 1652.16 million by 2029, exhibiting a CAGR of 4.50% during the forecast period.
This report provides a deep insight into the global Immuno-oncology Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immuno-oncology Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immuno-oncology Therapy market in any manner.
Global Immuno-oncology Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda
BioNTech SE
Allogene Therapeutics
IMAB-I-Mab Biopharma Co., Ltd.
Arcus Biosciences
Gritstone Oncology
Autolus Therapeutics
Rubius Therapeutics
Market Segmentation (by Type)
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Market Segmentation (by Application)
Hospitals
Ambulatory Surgical Center
Others
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Immuno-oncology Therapy Market
• Overview of the regional outlook of the Immuno-oncology Therapy Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immuno-oncology Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Markets Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Immuno-oncology Therapy
1.2 Key Market Segments
1.2.1 Immuno-oncology Therapy Segment by Type
1.2.2 Immuno-oncology Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Immuno-oncology Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Immuno-oncology Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Immuno-oncology Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Immuno-oncology Therapy Market Competitive Landscape
3.1 Global Immuno-oncology Therapy Sales by Manufacturers (2019-2024)
3.2 Global Immuno-oncology Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Immuno-oncology Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Immuno-oncology Therapy Sales Sites, Area Served, Product Type
3.6 Immuno-oncology Therapy Market Competitive Situation and Trends
3.6.1 Immuno-oncology Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Immuno-oncology Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Immuno-oncology Therapy Industry Chain Analysis
4.1 Immuno-oncology Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Immuno-oncology Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Immuno-oncology Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immuno-oncology Therapy Sales Market Share by Type (2019-2024)
6.3 Global Immuno-oncology Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Immuno-oncology Therapy Price by Type (2019-2024)
7 Immuno-oncology Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immuno-oncology Therapy Market Sales by Application (2019-2024)
7.3 Global Immuno-oncology Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Immuno-oncology Therapy Sales Growth Rate by Application (2019-2024)
8 Immuno-oncology Therapy Market Segmentation by Region
8.1 Global Immuno-oncology Therapy Sales by Region
8.1.1 Global Immuno-oncology Therapy Sales by Region
8.1.2 Global Immuno-oncology Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Immuno-oncology Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Immuno-oncology Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Immuno-oncology Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Immuno-oncology Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Immuno-oncology Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Amgen
9.1.1 Amgen Immuno-oncology Therapy Basic Information
9.1.2 Amgen Immuno-oncology Therapy Product Overview
9.1.3 Amgen Immuno-oncology Therapy Product Market Performance
9.1.4 Amgen Business Overview
9.1.5 Amgen Immuno-oncology Therapy SWOT Analysis
9.1.6 Amgen Recent Developments
9.2 AstraZeneca
9.2.1 AstraZeneca Immuno-oncology Therapy Basic Information
9.2.2 AstraZeneca Immuno-oncology Therapy Product Overview
9.2.3 AstraZeneca Immuno-oncology Therapy Product Market Performance
9.2.4 AstraZeneca Business Overview
9.2.5 AstraZeneca Immuno-oncology Therapy SWOT Analysis
9.2.6 AstraZeneca Recent Developments
9.3 Bristol-Myers Squibb
9.3.1 Bristol-Myers Squibb Immuno-oncology Therapy Basic Information
9.3.2 Bristol-Myers Squibb Immuno-oncology Therapy Product Overview
9.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Product Market Performance
9.3.4 Bristol-Myers Squibb Immuno-oncology Therapy SWOT Analysis
9.3.5 Bristol-Myers Squibb Business Overview
9.3.6 Bristol-Myers Squibb Recent Developments
9.4 Eli-Lilly
9.4.1 Eli-Lilly Immuno-oncology Therapy Basic Information
9.4.2 Eli-Lilly Immuno-oncology Therapy Product Overview
9.4.3 Eli-Lilly Immuno-oncology Therapy Product Market Performance
9.4.4 Eli-Lilly Business Overview
9.4.5 Eli-Lilly Recent Developments
9.5 Roche
9.5.1 Roche Immuno-oncology Therapy Basic Information
9.5.2 Roche Immuno-oncology Therapy Product Overview
9.5.3 Roche Immuno-oncology Therapy Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 GlaxoSmithKline
9.6.1 GlaxoSmithKline Immuno-oncology Therapy Basic Information
9.6.2 GlaxoSmithKline Immuno-oncology Therapy Product Overview
9.6.3 GlaxoSmithKline Immuno-oncology Therapy Product Market Performance
9.6.4 GlaxoSmithKline Business Overview
9.6.5 GlaxoSmithKline Recent Developments
9.7 Janssen Biotech
9.7.1 Janssen Biotech Immuno-oncology Therapy Basic Information
9.7.2 Janssen Biotech Immuno-oncology Therapy Product Overview
9.7.3 Janssen Biotech Immuno-oncology Therapy Product Market Performance
9.7.4 Janssen Biotech Business Overview
9.7.5 Janssen Biotech Recent Developments
9.8 Merck
9.8.1 Merck Immuno-oncology Therapy Basic Information
9.8.2 Merck Immuno-oncology Therapy Product Overview
9.8.3 Merck Immuno-oncology Therapy Product Market Performance
9.8.4 Merck Business Overview
9.8.5 Merck Recent Developments
9.9 Novartis
9.9.1 Novartis Immuno-oncology Therapy Basic Information
9.9.2 Novartis Immuno-oncology Therapy Product Overview
9.9.3 Novartis Immuno-oncology Therapy Product Market Performance
9.9.4 Novartis Business Overview
9.9.5 Novartis Recent Developments
9.10 Pfizer
9.10.1 Pfizer Immuno-oncology Therapy Basic Information
9.10.2 Pfizer Immuno-oncology Therapy Product Overview
9.10.3 Pfizer Immuno-oncology Therapy Product Market Performance
9.10.4 Pfizer Business Overview
9.10.5 Pfizer Recent Developments
9.11 Sanofi
9.11.1 Sanofi Immuno-oncology Therapy Basic Information
9.11.2 Sanofi Immuno-oncology Therapy Product Overview
9.11.3 Sanofi Immuno-oncology Therapy Product Market Performance
9.11.4 Sanofi Business Overview
9.11.5 Sanofi Recent Developments
9.12 Spectrum Pharmaceuticals
9.12.1 Spectrum Pharmaceuticals Immuno-oncology Therapy Basic Information
9.12.2 Spectrum Pharmaceuticals Immuno-oncology Therapy Product Overview
9.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Product Market Performance
9.12.4 Spectrum Pharmaceuticals Business Overview
9.12.5 Spectrum Pharmaceuticals Recent Developments
9.13 Takeda
9.13.1 Takeda Immuno-oncology Therapy Basic Information
9.13.2 Takeda Immuno-oncology Therapy Product Overview
9.13.3 Takeda Immuno-oncology Therapy Product Market Performance
9.13.4 Takeda Business Overview
9.13.5 Takeda Recent Developments
9.14 BioNTech SE
9.14.1 BioNTech SE Immuno-oncology Therapy Basic Information
9.14.2 BioNTech SE Immuno-oncology Therapy Product Overview
9.14.3 BioNTech SE Immuno-oncology Therapy Product Market Performance
9.14.4 BioNTech SE Business Overview
9.14.5 BioNTech SE Recent Developments
9.15 Allogene Therapeutics
9.15.1 Allogene Therapeutics Immuno-oncology Therapy Basic Information
9.15.2 Allogene Therapeutics Immuno-oncology Therapy Product Overview
9.15.3 Allogene Therapeutics Immuno-oncology Therapy Product Market Performance
9.15.4 Allogene Therapeutics Business Overview
9.15.5 Allogene Therapeutics Recent Developments
9.16 IMAB-I-Mab Biopharma Co., Ltd.
9.16.1 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Basic Information
9.16.2 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Overview
9.16.3 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Market Performance
9.16.4 IMAB-I-Mab Biopharma Co., Ltd. Business Overview
9.16.5 IMAB-I-Mab Biopharma Co., Ltd. Recent Developments
9.17 Arcus Biosciences
9.17.1 Arcus Biosciences Immuno-oncology Therapy Basic Information
9.17.2 Arcus Biosciences Immuno-oncology Therapy Product Overview
9.17.3 Arcus Biosciences Immuno-oncology Therapy Product Market Performance
9.17.4 Arcus Biosciences Business Overview
9.17.5 Arcus Biosciences Recent Developments
9.18 Gritstone Oncology
9.18.1 Gritstone Oncology Immuno-oncology Therapy Basic Information
9.18.2 Gritstone Oncology Immuno-oncology Therapy Product Overview
9.18.3 Gritstone Oncology Immuno-oncology Therapy Product Market Performance
9.18.4 Gritstone Oncology Business Overview
9.18.5 Gritstone Oncology Recent Developments
9.19 Autolus Therapeutics
9.19.1 Autolus Therapeutics Immuno-oncology Therapy Basic Information
9.19.2 Autolus Therapeutics Immuno-oncology Therapy Product Overview
9.19.3 Autolus Therapeutics Immuno-oncology Therapy Product Market Performance
9.19.4 Autolus Therapeutics Business Overview
9.19.5 Autolus Therapeutics Recent Developments
9.20 Rubius Therapeutics
9.20.1 Rubius Therapeutics Immuno-oncology Therapy Basic Information
9.20.2 Rubius Therapeutics Immuno-oncology Therapy Product Overview
9.20.3 Rubius Therapeutics Immuno-oncology Therapy Product Market Performance
9.20.4 Rubius Therapeutics Business Overview
9.20.5 Rubius Therapeutics Recent Developments
10 Immuno-oncology Therapy Market Forecast by Region
10.1 Global Immuno-oncology Therapy Market Size Forecast
10.2 Global Immuno-oncology Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Immuno-oncology Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Immuno-oncology Therapy Market Size Forecast by Region
10.2.4 South America Immuno-oncology Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Immuno-oncology Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Immuno-oncology Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Immuno-oncology Therapy by Type (2025-2030)
11.1.2 Global Immuno-oncology Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Immuno-oncology Therapy by Type (2025-2030)
11.2 Global Immuno-oncology Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Immuno-oncology Therapy Sales (Kilotons) Forecast by Application
11.2.2 Global Immuno-oncology Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Immuno-oncology Therapy
1.2 Key Market Segments
1.2.1 Immuno-oncology Therapy Segment by Type
1.2.2 Immuno-oncology Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Immuno-oncology Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Immuno-oncology Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Immuno-oncology Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Immuno-oncology Therapy Market Competitive Landscape
3.1 Global Immuno-oncology Therapy Sales by Manufacturers (2019-2024)
3.2 Global Immuno-oncology Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Immuno-oncology Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Immuno-oncology Therapy Sales Sites, Area Served, Product Type
3.6 Immuno-oncology Therapy Market Competitive Situation and Trends
3.6.1 Immuno-oncology Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Immuno-oncology Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Immuno-oncology Therapy Industry Chain Analysis
4.1 Immuno-oncology Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Immuno-oncology Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Immuno-oncology Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immuno-oncology Therapy Sales Market Share by Type (2019-2024)
6.3 Global Immuno-oncology Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Immuno-oncology Therapy Price by Type (2019-2024)
7 Immuno-oncology Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immuno-oncology Therapy Market Sales by Application (2019-2024)
7.3 Global Immuno-oncology Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Immuno-oncology Therapy Sales Growth Rate by Application (2019-2024)
8 Immuno-oncology Therapy Market Segmentation by Region
8.1 Global Immuno-oncology Therapy Sales by Region
8.1.1 Global Immuno-oncology Therapy Sales by Region
8.1.2 Global Immuno-oncology Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Immuno-oncology Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Immuno-oncology Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Immuno-oncology Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Immuno-oncology Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Immuno-oncology Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Amgen
9.1.1 Amgen Immuno-oncology Therapy Basic Information
9.1.2 Amgen Immuno-oncology Therapy Product Overview
9.1.3 Amgen Immuno-oncology Therapy Product Market Performance
9.1.4 Amgen Business Overview
9.1.5 Amgen Immuno-oncology Therapy SWOT Analysis
9.1.6 Amgen Recent Developments
9.2 AstraZeneca
9.2.1 AstraZeneca Immuno-oncology Therapy Basic Information
9.2.2 AstraZeneca Immuno-oncology Therapy Product Overview
9.2.3 AstraZeneca Immuno-oncology Therapy Product Market Performance
9.2.4 AstraZeneca Business Overview
9.2.5 AstraZeneca Immuno-oncology Therapy SWOT Analysis
9.2.6 AstraZeneca Recent Developments
9.3 Bristol-Myers Squibb
9.3.1 Bristol-Myers Squibb Immuno-oncology Therapy Basic Information
9.3.2 Bristol-Myers Squibb Immuno-oncology Therapy Product Overview
9.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Product Market Performance
9.3.4 Bristol-Myers Squibb Immuno-oncology Therapy SWOT Analysis
9.3.5 Bristol-Myers Squibb Business Overview
9.3.6 Bristol-Myers Squibb Recent Developments
9.4 Eli-Lilly
9.4.1 Eli-Lilly Immuno-oncology Therapy Basic Information
9.4.2 Eli-Lilly Immuno-oncology Therapy Product Overview
9.4.3 Eli-Lilly Immuno-oncology Therapy Product Market Performance
9.4.4 Eli-Lilly Business Overview
9.4.5 Eli-Lilly Recent Developments
9.5 Roche
9.5.1 Roche Immuno-oncology Therapy Basic Information
9.5.2 Roche Immuno-oncology Therapy Product Overview
9.5.3 Roche Immuno-oncology Therapy Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 GlaxoSmithKline
9.6.1 GlaxoSmithKline Immuno-oncology Therapy Basic Information
9.6.2 GlaxoSmithKline Immuno-oncology Therapy Product Overview
9.6.3 GlaxoSmithKline Immuno-oncology Therapy Product Market Performance
9.6.4 GlaxoSmithKline Business Overview
9.6.5 GlaxoSmithKline Recent Developments
9.7 Janssen Biotech
9.7.1 Janssen Biotech Immuno-oncology Therapy Basic Information
9.7.2 Janssen Biotech Immuno-oncology Therapy Product Overview
9.7.3 Janssen Biotech Immuno-oncology Therapy Product Market Performance
9.7.4 Janssen Biotech Business Overview
9.7.5 Janssen Biotech Recent Developments
9.8 Merck
9.8.1 Merck Immuno-oncology Therapy Basic Information
9.8.2 Merck Immuno-oncology Therapy Product Overview
9.8.3 Merck Immuno-oncology Therapy Product Market Performance
9.8.4 Merck Business Overview
9.8.5 Merck Recent Developments
9.9 Novartis
9.9.1 Novartis Immuno-oncology Therapy Basic Information
9.9.2 Novartis Immuno-oncology Therapy Product Overview
9.9.3 Novartis Immuno-oncology Therapy Product Market Performance
9.9.4 Novartis Business Overview
9.9.5 Novartis Recent Developments
9.10 Pfizer
9.10.1 Pfizer Immuno-oncology Therapy Basic Information
9.10.2 Pfizer Immuno-oncology Therapy Product Overview
9.10.3 Pfizer Immuno-oncology Therapy Product Market Performance
9.10.4 Pfizer Business Overview
9.10.5 Pfizer Recent Developments
9.11 Sanofi
9.11.1 Sanofi Immuno-oncology Therapy Basic Information
9.11.2 Sanofi Immuno-oncology Therapy Product Overview
9.11.3 Sanofi Immuno-oncology Therapy Product Market Performance
9.11.4 Sanofi Business Overview
9.11.5 Sanofi Recent Developments
9.12 Spectrum Pharmaceuticals
9.12.1 Spectrum Pharmaceuticals Immuno-oncology Therapy Basic Information
9.12.2 Spectrum Pharmaceuticals Immuno-oncology Therapy Product Overview
9.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Product Market Performance
9.12.4 Spectrum Pharmaceuticals Business Overview
9.12.5 Spectrum Pharmaceuticals Recent Developments
9.13 Takeda
9.13.1 Takeda Immuno-oncology Therapy Basic Information
9.13.2 Takeda Immuno-oncology Therapy Product Overview
9.13.3 Takeda Immuno-oncology Therapy Product Market Performance
9.13.4 Takeda Business Overview
9.13.5 Takeda Recent Developments
9.14 BioNTech SE
9.14.1 BioNTech SE Immuno-oncology Therapy Basic Information
9.14.2 BioNTech SE Immuno-oncology Therapy Product Overview
9.14.3 BioNTech SE Immuno-oncology Therapy Product Market Performance
9.14.4 BioNTech SE Business Overview
9.14.5 BioNTech SE Recent Developments
9.15 Allogene Therapeutics
9.15.1 Allogene Therapeutics Immuno-oncology Therapy Basic Information
9.15.2 Allogene Therapeutics Immuno-oncology Therapy Product Overview
9.15.3 Allogene Therapeutics Immuno-oncology Therapy Product Market Performance
9.15.4 Allogene Therapeutics Business Overview
9.15.5 Allogene Therapeutics Recent Developments
9.16 IMAB-I-Mab Biopharma Co., Ltd.
9.16.1 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Basic Information
9.16.2 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Overview
9.16.3 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Market Performance
9.16.4 IMAB-I-Mab Biopharma Co., Ltd. Business Overview
9.16.5 IMAB-I-Mab Biopharma Co., Ltd. Recent Developments
9.17 Arcus Biosciences
9.17.1 Arcus Biosciences Immuno-oncology Therapy Basic Information
9.17.2 Arcus Biosciences Immuno-oncology Therapy Product Overview
9.17.3 Arcus Biosciences Immuno-oncology Therapy Product Market Performance
9.17.4 Arcus Biosciences Business Overview
9.17.5 Arcus Biosciences Recent Developments
9.18 Gritstone Oncology
9.18.1 Gritstone Oncology Immuno-oncology Therapy Basic Information
9.18.2 Gritstone Oncology Immuno-oncology Therapy Product Overview
9.18.3 Gritstone Oncology Immuno-oncology Therapy Product Market Performance
9.18.4 Gritstone Oncology Business Overview
9.18.5 Gritstone Oncology Recent Developments
9.19 Autolus Therapeutics
9.19.1 Autolus Therapeutics Immuno-oncology Therapy Basic Information
9.19.2 Autolus Therapeutics Immuno-oncology Therapy Product Overview
9.19.3 Autolus Therapeutics Immuno-oncology Therapy Product Market Performance
9.19.4 Autolus Therapeutics Business Overview
9.19.5 Autolus Therapeutics Recent Developments
9.20 Rubius Therapeutics
9.20.1 Rubius Therapeutics Immuno-oncology Therapy Basic Information
9.20.2 Rubius Therapeutics Immuno-oncology Therapy Product Overview
9.20.3 Rubius Therapeutics Immuno-oncology Therapy Product Market Performance
9.20.4 Rubius Therapeutics Business Overview
9.20.5 Rubius Therapeutics Recent Developments
10 Immuno-oncology Therapy Market Forecast by Region
10.1 Global Immuno-oncology Therapy Market Size Forecast
10.2 Global Immuno-oncology Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Immuno-oncology Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Immuno-oncology Therapy Market Size Forecast by Region
10.2.4 South America Immuno-oncology Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Immuno-oncology Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Immuno-oncology Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Immuno-oncology Therapy by Type (2025-2030)
11.1.2 Global Immuno-oncology Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Immuno-oncology Therapy by Type (2025-2030)
11.2 Global Immuno-oncology Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Immuno-oncology Therapy Sales (Kilotons) Forecast by Application
11.2.2 Global Immuno-oncology Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings